Financial Highlights Second Quarter 2022: Revenue of $246.2 million, an increase of 16% from second quarter 2021 GAAP net loss of $490.0 million, which includes a $519.9 million loss on impairment related to our decision to exit the Episodes of Care Services segment. Non-GAAP adjusted EBITDA1 of $62.6 million, an increase of 15% from second … [Read more…]
FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, plans to participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 … [Read more…]
Q2 2022 reported revenue growth of 3.1% year-over-year (yoy); organic revenue growth of 8.8% Q2 2022 GAAP EPS $0.33; non-GAAP EPS $0.45, up 2.3% yoy Maintaining FY 2022 guidance for high, single-digit organic revenue growth, non-GAAP operating profit margin expansion and non-GAAP EPS increase BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (Nasdaq: BRKR) today announced financial results … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on … [Read more…]
– Monjuvi® U.S. net product sales of US$ 23.3 million (€ 21.7 million) for the second quarter 2022, a 25% Q-Q growth and 29% Y-Y growth – Efficacy and safety data of pelabresib for potential treatment improvement in myelofibrosis presented at EHA Congress 2022 – Entered into collaboration with Pfizer and Incyte for a combination … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2022. Second Quarter and Recent Highlights Reported quarterly revenue of $18.2 million in the second quarter of 2022 compared with $21.7 million in the second quarter of 2021 Revenue … [Read more…]
The Carnegie family of institutions salutes five individuals who are forces for positive change: Manu Chandaria, Lyda Hill, Dolly Parton, Lynn Schusterman, and Stacy Schusterman With a special presentation of the Carnegie Catalyst Award to: World Central Kitchen NEW YORK–(BUSINESS WIRE)–#CMoP–The international family of Carnegie institutions named five distinguished philanthropists as recipients of the 2022 … [Read more…]
MCMURRAY, Penn.–(BUSINESS WIRE)–In the latest Healthcare Business Strategy report, Mark Farrah Associates (MFA), www.markfarrah.com assessed administrative fees revenues from self-insured accounts for Blue Cross and Blue Shield (BCBS) plans and their affiliates. Based on statutory filings from the National Association of Insurance Commissioners (NAIC), BCBS entities reported receiving $18.7 billion in reimbursements in 2021 from … [Read more…]
Analysis finds that patients in some states pay nearly 26% of median income for their life-saving insulin Medicare coverage options vary by state, making it even more critical to choose the right plan, as it could save patients with diabetes thousands of dollars NEW YORK–(BUSINESS WIRE)–Chapter, the leading data-driven Medicare Advisor, has today issued a … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Physician-led healthcare organization WelbeHealth today announced that veteran healthcare law attorney Blaire Bernard has joined its leadership team as general counsel. Bernard has focused her 20-year legal career on supporting providers whose mission is to expand access to value-based care. Most recently she was general counsel at Iora Health. After Iora Health … [Read more…]
